Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Heyu Biological Technology Corp | f10q0320ex32-1_heyubio.htm |
| EX-31.2 - CERTIFICATION - Heyu Biological Technology Corp | f10q0320ex31-2_heyubio.htm |
| EX-31.1 - CERTIFICATION - Heyu Biological Technology Corp | f10q0320ex31-1_heyubio.htm |
| 10-Q - QUARTERLY REPORT - Heyu Biological Technology Corp | f10q0320_heyubiologicaltech.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, in her capacity as an officer of Heyu Biological Technology Corporation (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of her knowledge:
(1) The Quarterly Report of the Company on Form 10-Q for the quarter ended March 31, 2020, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 15, 2020
| /s/ Wendy Wei Li | |
| Wendy Wei Li | |
| Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of a separate disclosure document.